Markus Britschgi

11.3k total citations · 3 hit papers
40 papers, 4.7k citations indexed

About

Markus Britschgi is a scholar working on Physiology, Pharmacology and Immunology. According to data from OpenAlex, Markus Britschgi has authored 40 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 14 papers in Pharmacology and 13 papers in Immunology. Recurrent topics in Markus Britschgi's work include Drug-Induced Adverse Reactions (14 papers), Alzheimer's disease research and treatments (12 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Markus Britschgi is often cited by papers focused on Drug-Induced Adverse Reactions (14 papers), Alzheimer's disease research and treatments (12 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Markus Britschgi collaborates with scholars based in Switzerland, United States and United Kingdom. Markus Britschgi's co-authors include Werner J. Pichler, Tony Wyss‐Coray, Ramya Narasimhan, Kurt M. Lucin, Edward Rockenstein, Eliezer Masliah, Eric Prinssen, Philipp A. Jaeger, Brian Spencer and Stephen Toovey and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Markus Britschgi

39 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice

2008 898 citations Eliezer Masliah, Markus Britschgi et al. Journal of Clinical Investigation profile →
Maternal immune activation and abnormal brain development across CNS disorders

2014 631 citations Irène Knuesel, Laurie Chicha et al. Nature Reviews Neurology profile →
Cryo-EM structure of alpha-synuclein fibrils

2018 441 citations Ricardo Guerrero-Ferreira, Nicholas M. I. Taylor et al. eLife profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Britschgi Switzerland	32	1.4k	1.2k	923	826	823	40	4.7k
Masahiro Nishibori Japan	46	914 0.6×	539 0.5×	2.9k 3.1×	697 0.8×	1.4k 1.7×	288	7.8k
Yukitoshi Takahashi Japan	34	365 0.3×	813 0.7×	879 1.0×	356 0.4×	138 0.2×	284	4.4k
Kirk W. Johnson United States	46	2.1k 1.5×	430 0.4×	2.6k 2.8×	356 0.4×	748 0.9×	137	7.6k
C. Bountra United Kingdom	39	2.2k 1.6×	700 0.6×	2.9k 3.2×	250 0.3×	306 0.4×	91	6.7k
Ralf A. Linker Germany	39	572 0.4×	170 0.1×	2.1k 2.3×	377 0.5×	1.0k 1.2×	151	6.5k
Sylvain Chemtob Canada	59	1.6k 1.1×	1.1k 0.9×	4.5k 4.9×	1.2k 1.4×	975 1.2×	328	11.8k
Tetsuya Mizuno Japan	49	1.4k 1.0×	237 0.2×	2.1k 2.3×	329 0.4×	2.8k 3.4×	169	7.8k
Wenying Wang China	31	749 0.5×	236 0.2×	1.9k 2.1×	316 0.4×	672 0.8×	191	4.7k
Yan Wu China	40	963 0.7×	662 0.6×	1.9k 2.1×	341 0.4×	1.1k 1.4×	170	5.5k
Robert E. Mrak United States	51	3.8k 2.7×	483 0.4×	3.1k 3.4×	746 0.9×	3.4k 4.1×	143	9.4k

Countries citing papers authored by Markus Britschgi

Since Specialization

Citations

This map shows the geographic impact of Markus Britschgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Britschgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Britschgi more than expected).

Fields of papers citing papers by Markus Britschgi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Britschgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Britschgi. The network helps show where Markus Britschgi may publish in the future.

Co-authorship network of co-authors of Markus Britschgi

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Britschgi. A scholar is included among the top collaborators of Markus Britschgi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Britschgi. Markus Britschgi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brevé, John J. P., Walter Boiten, Bram van der Gaag, et al.. (2025). Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson’s disease. Nature Communications. 16(1). 6630–6630. 2 indexed citations

Rodríguez-Iglesias, Noelia, Iñaki Paris, Jorge Valero, et al.. (2024). A bottom‐up approach identifies the antipsychotic and antineoplastic trifluoperazine and the ribose derivative deoxytubercidin as novel microglial phagocytosis inhibitors. Glia. 73(2). 330–351. 1 indexed citations

Gordevičius, Juozas, Peipei Li, Lee Marshall, et al.. (2021). Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease. Nature Communications. 12(1). 5134–5134. 22 indexed citations

Guerrero-Ferreira, Ricardo, Nicholas M. I. Taylor, Ana‐Andreea Arteni, et al.. (2019). Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. eLife. 8. 222 indexed citations

Navarro, Paula P., Christel Genoud, Daniel Castaño‐Díez, et al.. (2018). Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles. Scientific Reports. 8(1). 18046–18046. 23 indexed citations

Knuesel, Irène, Laurie Chicha, Markus Britschgi, et al.. (2014). Maternal immune activation and abnormal brain development across CNS disorders. Nature Reviews Neurology. 10(11). 643–660. 631 indexed citations breakdown →

Toovey, Stephen, Eric Prinssen, Craig R. Rayner, et al.. (2012). Post-Marketing Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: An Updated Review. Advances in Therapy. 29(10). 826–848. 31 indexed citations

Britschgi, Markus, et al.. (2012). Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice. Journal of Neuroinflammation. 9(1). 220–220. 39 indexed citations

Tyson, Trevor, et al.. (2012). Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?. Molecular Neurobiology. 47(2). 561–574. 171 indexed citations

10.

Fukuhara, Takeshi, Markus Britschgi, Yingbo He, et al.. (2011). Complement Receptor 2Is Expressed in Neural Progenitor Cells and Regulates Adult Hippocampal Neurogenesis. Journal of Neuroscience. 31(11). 3981–3989. 73 indexed citations

11.

Britschgi, Markus. (2008). Blood Protein Signature for the Early Diagnosis of Alzheimer Disease. Archives of Neurology. 66(2). 161–161. 40 indexed citations

12.

Lerch, Marianne, Monika Keller, Markus Britschgi, et al.. (2007). Cross-reactivity patterns of T cells specific for iodinated contrast media. Journal of Allergy and Clinical Immunology. 119(6). 1529–1536. 61 indexed citations

13.

Britschgi, Markus & Tony Wyss‐Coray. (2007). Systemic and Acquired Immune Responses in Alzheimer's Disease. International review of neurobiology. 82. 205–233. 89 indexed citations

14.

Spanou, Zoi, Patrick Schaerli, Markus Britschgi, et al.. (2006). T-Cell Regulated Neutrophilic Inflammation in Auto-Inflammatory Diseases. Journal of Allergy and Clinical Immunology. 117(2). S21–S21. 3 indexed citations

15.

Spanou, Zoi, Monika Keller, Markus Britschgi, et al.. (2006). Involvement of Drug-Specific T Cells in Acute Drug-Induced Interstitial Nephritis. Journal of the American Society of Nephrology. 17(10). 2919–2927. 96 indexed citations

16.

Schaerli, Patrick, Markus Britschgi, Monika Keller, et al.. (2004). Characterization of Human T Cells That Regulate Neutrophilic Skin Inflammation. The Journal of Immunology. 173(3). 2151–2158. 126 indexed citations

17.

Naisbitt, Dean J., Markus Britschgi, G. A. E. Wong, et al.. (2003). Hypersensitivity Reactions to Carbamazepine: Characterization of the Specificity, Phenotype, and Cytokine Profile of Drug-Specific T Cell Clones. Molecular Pharmacology. 63(3). 732–741. 175 indexed citations

18.

Britschgi, Markus & Werner J. Pichler. (2002). Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Current Opinion in Allergy and Clinical Immunology. 2(4). 325–331. 96 indexed citations

19.

Burkhart, Christoph, Markus Britschgi, Jan P.H. Depta, et al.. (2002). Non‐covalent presentation of sulfamethoxazole to human CD4⁺ T cells is independent of distinct human leucocyte antigen‐bound peptides. Clinical & Experimental Allergy. 32(11). 1635–1643. 44 indexed citations

20.

Britschgi, Markus, Urs C. Steiner, Simone Schmid, et al.. (2001). T-cell involvement in drug-induced acute generalized exanthematous pustulosis. Journal of Clinical Investigation. 107(11). 1433–1441. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact